Artelo Biosciences, Inc.

US$1.91As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ARTLHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (64.38%)
Div yield —
ROE (705.71%)
Biotechnology
Beta (5Y) (0.01)
PE TTM —
TSR TTM (97.72%)
Mkt cap US$1.046M
ROIC (306.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.28
19.34%
(8.73%)
Hold 7|5|12|9|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
27.94%
32.69%
19.40%
8.63%
Revenue$M
0.138
0.145
0.142
0.148
14.28%
21.25%
12.61%
12.10%
Peers (US$1.046M)
Cap (US$)
PE
1.130M
—
0.915M
—
Capital
TTM
5Y
10Y
Leveragex
11.04
0.103
0.073
EBIT/Intx
7.005
0.530
0.575
Own earn%
(76.94)
(91.00)
(73.71)
Sh yield%
48.95
38.66
38.31
Owners
Insiders/Inst%
4.65
48.69
Short interest%
4.02
SBC / revenue%
3.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
0–5
$1 testx
0.1
Incr. ROIC%
0